Stay updated on Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial
Sign up to get notified when there's something new on the Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial page.

Latest updates to the Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial page
- Check3 days agoChange DetectedThe footer’s site revision changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check9 days agoChange DetectedA banner announces NIH transition updates and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” under Executive Order 14434.SummaryDifference1%

- Check16 days agoChange DetectedThe footer’s site revision label changes from v3.7.1 to v3.7.2 while the page remains a 403 error.SummaryDifference0.2%

- Check23 days agoChange DetectedThe ClinicalTrials.gov footer revision changes from v3.7.0 to v3.7.1, while the study page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check44 days agoChange DetectedAccess to the study record is blocked by a 403 Forbidden page, replacing the expected study details with an error screen. The change effectively removes the visible content and navigation for this study on that page.SummaryDifference20%

- Check65 days agoChange DetectedThe revision label at the bottom of the page updated from v3.6.5 to v3.6.6, signaling a new site version.SummaryDifference0.0%

Stay in the know with updates to Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial page.